Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00871208Phase 4Withdrawn
A Phase 4 trial of retapamulin in atopic dermatitis (AD), sponsored by St. Luke's-Roosevelt Hospital Center. Planned start May 2009; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00871208.